MaaT Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20%.

Top 10 shareholders own 74.37% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
20.1%	Bpifrance Participations SA	2,802,439	€21.5m	55.5%	0.16%
18.9%	Seventure Partners	2,630,568	€20.2m	-40.1%	52.58%
14.6%	Symbiosis LLC	2,027,702	€15.5m	0%	no data
10.2%	Crédit Mutuel Innovation	1,412,364	€10.8m	0%	29.91%
8.87%	BIOCODEX - Incubação de Empresas de Ciências da Vida, S.A.	1,234,185	€9.5m	0%	no data
1.68%	Herve Affagard	233,605	€1.8m	0%	no data
0.037%	Financiere Arbevel	5,162	€39.5k	0%	0.01%
0.017%	Simplify Asset Management Inc.	2,397	€18.4k	76%	no data
0.014%	Karim Dabbagh	1,960	€15.0k	0%	no data
0.0098%	Propel Bio Management, LLC	1,362	€10.4k	0%	0.01%